Maximize Returns on Inhibrx Inc. (INBX) Investments Using Our Online Dividend Calculator.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
OppFi Inc.
BlackRock 2037 Municipal Target Term Trust of Beneficial Interest
NexPoint Diversified Real Estate Trust
EATON VANCE MUNICIPAL INCOME 2028
Euroseas Ltd. (Marshall Islands)
BankFinancial Corporation
Virco Manufacturing Corporation
BNY Mellon Municipal Bond Infrastructure Fund Inc.